SCPHARMACEUTICALS INC. UP TO $50,000,000 SHARES OF COMMON STOCK AMENDED AND RESTATED SALES AGREEMENTSales Agreement • March 13th, 2024 • scPharmaceuticals Inc. • Pharmaceutical preparations • New York
scPharmaceuticals Inc., a Delaware corporation (the “Company”), and Cowen and Company, LLC (“TD Cowen”), are parties to that certain Sales Agreement dated March 23, 2021 (the “Original Agreement”). The Company and TD Cowen desire to amend and restate the Original Agreement in its entirety as set forth in this Amended and Restated Sales Agreement (this “Agreement”).
